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Objective: Durability of the valve seems to be dependent on the remodeling ability
of the valve itself, which is controlled by both collagen synthesis and collagenolyt-
ic activity of valvular fibroblasts and endothelial cells. However, the balance of col-
lagen synthesis and collagenolysis of the cryopreserved valve has not yet been
clearly revealed. Thus, we assessed the collagen synthesis and collagenolysis abili-
ty of the cryopreserved valve.
Methods: Twelve valves were divided into 2 groups: freshly harvested valves (n =
6) and cryopreserved valves (n = 6). We measured the collagen content using Sirius
red, a dye selective to the collagen. Collagen synthesis was evaluated by means of
the tritiated proline incorporation method. Noncollagenase-digestible counts, which
represent protein synthesis, and collagenase-digestible counts, which represent col-
lagen synthesis, were estimated. Collagenase activity of the valves was assessed by
gelatin zymography.
Results: The collagen content of the cryopreserved group was maintained. The non-
collagenase-digestible counts of the cryopreserved group decreased from 3862 ±
1180 counts/mg to 1174 ± 1362 counts/mg, and the collagenase-digestible counts
of the cryopreserved group were 831 ± 762 counts/mg compared with the value of
1062 ± 136 counts/mg for the freshly harvested group. The collagenase activity of
the cryopreserved group was observed at the same level as that of the freshly har-
vested group, despite the serious endothelial damage of the cryopreserved valves.
Conclusions: Although the collagen synthesis of cryopreserved valves was relative-
ly maintained, the protein synthesis was highly diminished, and the collagenolysis
ability was activated immediately after the thawing process. These results imply
that the cryopreservation procedure itself may cause the collagen metabolism to be
on the degradable side, which will lead to valve failure.
Over the past decade, several investigators, including us, havereported that loss of endothelial cells of cryopreserved valves maybe inevitable, even with the current preservation techniques.Therefore, prolonged valve competence and durability of cryopre-served valves have been thought to be derived from the viabilityof the donor fibroblast, which can remodel the matrix assembly,1-3
or the quality of the original collagenous skeleton, which is the main component of
the matrix assembly. There are some experimental studies that favor persistence of
donor fibroblast viability after implantation.4-7 On the other hand, some clinical
studies do not favor donor fibroblast viability after implantation and insist on pre-
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serving the intact original collagen network,8-12 which pro-
vides the structural basis of the valve matrix, for the long-
term performance of allograft valves. Controlled col-
lagenolysis ability is thought to play an important role as the
first step of the remodeling process,13 and consequent colla-
gen synthesis is a second step. The present investigation was
undertaken to examine the collagenolytic activity and colla-
gen synthesis of cryopreserved valves.
Materials and Methods
Collection and Processing of Cryopreserved Valves
Twelve fresh porcine hearts were obtained from a local slaughter-
house immediately after the animals’ deaths and immediately
placed into the transport medium (cold Ringer’s lactate solution).
The pulmonary valves were dissected, and each cusp was excised
in our laboratory within 1 hour after death. All cusps were divided
into 2 groups: freshly harvested cusps (n = 6) and cryopreserved
cusps (n = 6). The cryopreservation technique was that of
Tominaga and associates.14 In brief, after antibiotic sterilizing
treatment (240 µg/mL cefazolin, 120 µg/mL lincomycin, 50
µg/mL vancomycin, and 100 µg/mL polymyxin B) at 4°C for 24
hours, the cryopreserved specimens were transferred to TC199 cul-
ture medium with 5% N-2-hydroxyethylpiperazine-N-2-ethanesul-
fonic acid buffer, 10% calf serum, and 10% dimethyl sulfoxide
(Fisher Scientific Co, Pittsburgh, Pa) and were frozen with a pro-
grammable freezer (Cryomed model 1050; Forma Scientific Co,
Marietta, Ohio) that lowered the temperature 1°C per minute down
to a temperature of –80°C. The specimens were immediately
immersed in the vapor phase of a liquid nitrogen freezer (–196°C).
After a week of storage, the cryopreserved specimens were thawed
immediately in a 40°C shaken water bath and then analyzed.
Qualitative Analysis of Collagen Fiber and
Measurement of Collagen Contents
Sirius red (Muto Pure Chemicals, Tokyo, Japan) is a dye selective
to the collagen.15,16 First, we visualized the collagen fibers of a
cryopreserved crude cusp with a confocal scanning microscope
because some fixing and slicing procedures may be influenced on
them.14 Next, we measured the collagen contents. In brief, the
cusps were immersed in 2 mL of saturated picric acid containing
0.1% Sirius red in a 35-mm culture dish. The dishes were gently
shaken at room temperature for 30 minutes in the dark. After
staining, the cusps were rinsed 5 times with distilled water until
the fluid was colorless. The cusps were put into a tube with 1 mL
of 0.1 N NaOH in absolute methanol (1:1, vol/vol). Each tube was
gently shaken for a minute with the vortex mixer, and all the dye
was eluted from the cusps. The amount of eluted dye was mea-
sured in a spectrophotometer at 540 nm (ie, the wavelength corre-
sponding to the maximal absorbency of Sirius red).
Measurement of Collagen and Protein Synthesis
The protein production, including collagen, was assessed by using
the tritiated (3H) proline (L-[2, 3-3H] proline; Amersham
International, Little Chalfont, United Kingdom) incorporation
method.17,18 Total 3H-proline incorporation into a cusp for 24
hours was expressed as noncollagenase-digestible counts (NDCs),
which represents the total protein synthesis of the cusp. 3H-proline
incorporation into the collagenous proteins of a cusp was estimat-
ed as collagenase-digestible counts (CDCs), which represent the
collagen synthesis of the cusp. Each cusp was cut into 2 pieces.
One half of the cusp was used for NDC analysis, and the other half
was used for CDC analysis.
In brief, after the cusps had been washed with phosphate-
buffered saline solution, each half cusp was placed in a 35-mm
dish with 2 mL of minimum essential medium plus ascorbic acid
(50 µg/mL) with 5% serum albumin. One and one-half hours
later, the medium was replaced by 2 mL of the same medium
plus β-amino-propionitrile (50 µg/mL) and 74 KBq/mL 3H-
proline, and the cusp was incubated for 24 hours. After this
labeling period, 2 mL of 50 mmol/L Tris-HCl (pH 7.6 contain-
ing 0.25 mol/L ethylenediamine tetraacetic acid), 0.1 mol/L N-
ethylmaleimide, and 10 mmol/L phenylmethylsulfonyl fluoride
was added to each dish, and the residual 3H-proline was
removed. After being washed with 50 mmol/L Tris-HCl (pH 7.6
containing 1 mmol/L proline), each half cusp was cut into pieces
with 1 mL of medium.
For the assay of NDCs, a 10% trichloroacetic acid (TCA) solu-
tion was added to each dish to precipitate the protein, and the spec-
imens were centrifuged (2000 rpm) for 5 minutes. The radioactive
sediments were separated from free 3H-proline by means of repeat-
ed (3×) washes with 5% TCA containing 1 mmol/L proline. The
final sediments were suspended in 0.75 mL of 0.2 mol/L NaOH
and neutralized by the addition of 0.3 mL of 1 mol/L N-2-hydroxy-
ethylpiperazine-N-2-ethanesulfonic acid buffer and 0.3 mL of 0.15
mol/L HCl. The radioactivity of the suspensions from this solution
was measured as NDCs.
For the evaluation of CDCs, 0.5 mL of 20 mmol/L Tris-HCl
(pH 7.6 containing 50 mmol/L CaCl2) and 0.2 mL of 24 IU colla-
genase (Muto Pure Chemicals) was added to a 3H-proline–labeled
half cusp, which was cut into pieces. The mixture was then incu-
bated for 3 hours at 37°C for collagen digestion. The digestion was
Figure 1. Photomicrograph of a cryopreserved porcine heart cusp
with Sirius red dye. Collagen fibers are stained red. (Original mag-
nification 200×.)
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terminated by the addition of TCA and tannic acid up to final con-
centrations of 0.3 mmol/L and 1.5 mmol/L, respectively. After cen-
trifugation (10 minutes at 3000 rpm), the supernatant was counted
in a liquid scintillation counter. CDCs and NDCs were quantified
per half cusp wet weights.
Analysis of Collagenase Activity
Collagenolytic activity was identified by gelatin substrate zymog-
raphy, which was obtained by means of electrophoresis in the pres-
ence of sodium dodecylsulfate in polyacrylamide gel containing 1
mg/mL gelatin (Sigma Chemical Co, St Louis, Mo).19-21 In brief,
culture medium after 24 hours’ incubation of a specimen without
growth factors was used for this assay. A mixture of a 45-µL sam-
ple and 15 µL of conditioned buffer was loaded onto the gel.
Molecular weight standard proteins (Bio-Rad, Hercules, Calif)
were run simultaneously. After electrophoresis, the gel was washed
twice with 2% Triton X100 for 1 hour to remove sodium dodecyl-
sulfate with 10 mmol/L Tris-HCl (pH 8.0) and subsequently incu-
bated for 18 hours at 37°C in 50 mmol/L Tris-HCl (pH 8.0) con-
taining 10 mmol/L CaCl2 and 1 µmol/L ZnCl2. After fixation by a
50% methanol and 5% acetic acid solution, the gel was stained
with 1% Coomassie Blue R250 dye. Collagenase activity appeared
as clear bands within the stained gel.
Densitometric Estimation of Collagenase
The intensities of the bands were measured on a Power Macintosh
G3 computer (Apple Computer, Cupertino, Calif) with an optical
scanner with the public domain National Institutes of Health Image
1.61 software.
Western Blotting of Collagenase
Immunoblot analysis was carried out as previously described.22,23
Proteins in the gel were transferred to nitrocellulose membranes.
Before probing, the membrane was blocked in 5% bovine serum
albumin in Tris-buffered saline solution (pH 7.6) containing 0.1%
Tween-20 (TBS-T) at 4°C overnight. Then the membrane was
probed in fresh blocking buffer containing either anti-matrix met-
alloproteinase 1 (anti-MMP-1), anti-MMP-2, or anti-MMP-9
(Chemicon, Boronia, Victoria, Australia) for 1 hour at room tem-
perature. After extensive washing with TBS-T, a secondary anti-
body reaction was performed with horseradish peroxidase–conju-
gated donkey anti-rabbit immunoglobulin at a dilution of 1:5000 in
TBS-T. After a final wash, the membrane was treated with Western
blotting detection reagents and Hyperfilm-enhanced chemilumi-
nescence reagents (Amersham Pharmacia Biotech UK Limited,
Little Chalfont, Buckinghamshire, United Kingdom), and chemi-
luminescence was detected by means of exposure to enhanced
chemiluminescence.
Statistical Analysis
The value of collagen contents of each cryopreserved cusp was
expressed as a percentage of that of each corresponding fresh cusp.
NDCs and CDCs were expressed as actual counts. The values of 6
cusps were averaged (means ± SD). Paired data were compared by
using a t test (Microsoft Excel 98; Microsoft Corp, Redmond,
Wash).
Results
Collagen Fiber and Contents in Cryopreserved Cusps
Collagen fibers of the cryopreserved cusp were specifically
stained with the Sirius red dye, as shown in Figure 1.
Among the cryopreserved cusps, collagen contents them-
selves were maintained at 102% ± 20.6% of those of the
freshly harvested cusps. There was no significant difference
(P = .56) between the collagen contents of the freshly pre-
served cusps and those of the cryopreserved cusps immedi-
ately after the thawing process.
Collagen and Protein Synthesis in Cryopreserved
Cusps
Among cryopreserved cusps, NDCs (ie, one parameter of
the protein synthesis) decreased significantly (P = .0019),
from 3862 ± 1180 counts/mg to 1174 ± 1362 counts/mg
(Figure 2). However, among cryopreserved cusps, CDCs (ie,
the parameter of the collagen synthesis) were preserved at
831 ± 762 counts/mg compared with 1062 ± 136 counts of
the freshly preserved cusps (P = .45). A curious discrepan-
cy between the collagen synthesis ability and the protein
synthesis ability of the cryopreserved cusps was observed
immediately after the thawing process.
Collagenase Activity in Cryopreserved Cusps
Three major gelatinolytic (collagenolytic) bands were found
in the gelatin zymography of both groups (Figure 3, A). These
gelatinolytic bands were ascertained to be MMP-1 and MMP-
Figure 2. Collagen and protein synthesis of fresh (FRES) and cry-
opreserved (CRYO) cusps. Open columns show NDCs, and
hatched columns show CDCs. Values are expressed as radioac-
tive counts per milligram wet weight of cusp (means ± SD). Values
were significantly different (P < .05) when compared with those of
freshly harvested group.
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2 according to the molecular weight standards and the Western
Blot analysis (Figure 3, B). The collagenase activity of the
cryopreserved group was observed at the same level as that of
the freshly preserved group immediately after the thawing
process (Figure 3, C).
Discussion
The long-term durability of the cryopreserved allograft
valves has not yet been fully achieved. Some reports point-
ed out the deterioration and malfunction of the implanted
cryopreserved valves.4-7 Mitchell and colleagues8 morpho-
logically reported the nonviability and the flattened collagen
network of the cryopreserved allograft valves and suggested
that their usual degeneration cannot be attributed to
immunologic response.15 However, these precise mecha-
nisms of the degenerative changes and the allograft valve
failure have not yet been clearly revealed.
Durability of the cryopreserved valves seems to be
dependent on the fibroblast viability.1-3 Lupinetti and asso-
ciates4,5 demonstrated the presence of procollagen and the
Figure 3. A, Gelatin zymogram of fresh and cryopreserved cusps. There are 3 major gelatinolytic bands. Molecular
weights of MMP-1, MMP-2, and MMP-9 are 54, 72, and 92 kd, respectively. B, Western blot analysis of the fresh and
cryopreserved cusps. Bands of MMP-1 and MMP-2 are detected. C, Densitometric evaluation of the fresh and cryo-
preserved cusps. Activity of MMP-1 and MMP-2 in the supernatant of the cryopreserved cusps was observed at the
quantitatively same degree as those of the fresh cusps. FRES, Freshly preserved cusps; CRYO, cryopreserved cusps.
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α1-(I) procollagen gene expression in aortic allograft valves
after implantation for 3 days, which suggested the viability
of donor fibroblasts. Fibroblasts have been known to exist
within the matrix and participate in the valve remodeling
through the collagen metabolism. In our present study the
collagen content in the cryopreserved cusps was kept at the
same degree as that of the fresh cusps, and the collagen syn-
thesis ability in the cryopreserved cusps was also relatively
preserved. However, the protein synthesis ability, including
collagen synthesis, in the cryopreserved cusps decreased
significantly, although the collagen synthesis ability is pre-
served, like the data of Lupinetti and associates, and there-
fore much reduction of protein synthesis ability remains to
be discussed.
The MMPs are a family of zinc-dependent enzymes that
are able to digest a wide range of extracellular matrix pro-
teins.13 The expression of the MMPs from the endothelial
cells, the fibroblast cells, and the ischemic myocardium was
consecutively revealed.20-23 MMP-1, the interstitial collage-
nase, is mainly produced from the fibroblast and is known
to degrade structural type I collagen in the matrix. MMP-2
and MMP-9 are mainly produced from the endothelium and
are known to be involved in the degradation of type IV col-
lagen that is a major component of the subendothelial base-
ment membrane.13,24
Our previous study demonstrated that the cytosolic
and mitochondrial functions of endothelial cells were
damaged seriously during the cryopreservation and thaw-
ing processes, and those processes may cause a latent
cytosolic and mitochondrial injury, even in the fibrob-
lasts.14 Despite the anticipated reduced cellular viability,
particularly that of endothelial cells, in the cryopreserved
cusps, the activity of the MMP-1 and MMP-2 in the
supernatant of the cryopreserved cusps was observed at
the quantitatively same degree as those of the fresh
cusps. These results imply that the cryopreservation and
thawing process cause MMP-1 and MMP-2 release from
endothelial and fibroblast cells of allograft cusps and
activate them before the implantation. There is a possi-
bility that the activated MMP-2 will degrade the base-
ment membrane consisting of type IV collagen and that
activated MMP-1 will destroy the cusp matrix. Most cryo-
preserved valves may have the potential to degrade the
matrix.
From those apparently discrepant results, we think that
the collagen synthesis ability is preserved, even in the
slightly injured fibroblast cells of cryopreserved valves;
however, the protein synthesis ability might be extremely
reduced because of limited endothelial collaboration25,26
and the decrease of the protein production relevant to the
intracellular organellar function, which maintains the cell
viability.14 Furthermore, the collagenolytic activation
occurs just before implantation and must be considered. As
to those results, the injured fibroblasts are going to be non-
viable. Collagen synthesis might be supposed to deteriorate,
and the original collagenous skeleton degrades in the near
future.
Although it is necessary to elucidate the dynamics of tis-
sue inhibitors of MMPs in the cryopreserved valves, the
control of the MMPs’ activity in the cryopreserved valves
may become more effective to obtain the long-term durabil-
ity rather than the preservation of collagen synthesis ability.
Recently, there were some reports that doxycycline, a deriv-
ative of tetracycline, suppresses the development of the elas-
tase-induced abdominal aortic aneurysms through direct
MMP-inhibiting activities.27 Other MMP inhibitors, mari-
mastat (BB-2516),28 batimastat (BB-94), and BE16627B,
are also developed as agents for the inhibition of cancer
metastasis. These agents might improve the allograft preser-
vation for clinical use.
In conclusion, this study suggests the possibility that the
cryopreservation and thawing processes themselves may
cause the collagenolytic activation and the latent degrada-
tion of collagen synthesis in a cryopreserved valve, which
will lead to the destruction of the valve matrix. Further
examination for collagen metabolism and modulation of the
collagenolytic activity will be necessary to improve the allo-
graft preservation for better clinical use.
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